- Home
- Publications
- Publication Search
- Publication Details
Title
Metallo-Drugs in Cancer Therapy: Past, Present and Future
Authors
Keywords
-
Journal
MOLECULES
Volume 27, Issue 19, Pages 6485
Publisher
MDPI AG
Online
2022-10-10
DOI
10.3390/molecules27196485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metal Complexes in Diagnosis and Therapy
- (2022) Diego Tesauro INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New Cu+2 Complexes with N-Sulfonamide Ligands: Potential Antitumor, Antibacterial, and Antioxidant Agents
- (2022) Adriana Corina Hangan et al. MOLECULES
- Nanocluster-Based Drug Delivery and Theranostic Systems: Towards Cancer Therapy
- (2022) Alma Lucia Villela Zumaya et al. Polymers
- First-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumor activity
- (2021) Delia Hernández-Romero et al. COORDINATION CHEMISTRY REVIEWS
- Ruthenium Complexes as Promising Candidates against Lung Cancer
- (2021) Qi Sun et al. MOLECULES
- Latest developments in metal complexes as anticancer agents
- (2021) Renata Paprocka et al. COORDINATION CHEMISTRY REVIEWS
- Single-Cell Chemistry of Photoactivatable Platinum Anticancer Complexes
- (2021) Elizabeth M. Bolitho et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Coordination compounds of biogenic metals as cytotoxic agents in cancer therapy
- (2021) Dmitry A. Guk et al. RUSSIAN CHEMICAL REVIEWS
- Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
- (2020) Golara Golbaghi et al. MOLECULES
- Synthesis, Characterization and Biological Activity of Two New Copper (II) Complexes with N-sulfonamide Ligand
- (2020) Adriana Corina Hangan et al. REVISTA DE CHIMIE
- Synthesis, characterization of inclusion compounds of amygdalin with β-cyclodextrin and sod-like activity and cytotoxicity on hela tumor cells
- (2020) Eleonora Marian et al. Arabian Journal of Chemistry
- Novel Copper-Containing Cytotoxic Agents Based on 2-Thioxoimidazolones
- (2020) Olga O. Krasnovskaya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives
- (2020) Sang Yeul Lee et al. Drug Design Development and Therapy
- Air pollution and the number of daily deaths due to respiratory causes in Tehran
- (2020) Behrooz Karimi et al. ATMOSPHERIC ENVIRONMENT
- Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
- (2019) Reece G. Kenny et al. CHEMICAL REVIEWS
- Metal-based antitumor compounds: beyond cisplatin
- (2019) Peter V Simpson et al. Future Medicinal Chemistry
- NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
- (2019) Enzo Alessio et al. MOLECULES
- The World Cancer Research Fund/American Institute for Cancer Research Third Expert Report on Diet, Nutrition, Physical Activity, and Cancer: Impact and Future Directions
- (2019) Steven K Clinton et al. JOURNAL OF NUTRITION
- Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
- (2018) Samuel M. Meier-Menches et al. CHEMICAL SOCIETY REVIEWS
- The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
- (2018) Alberta Bergamo et al. COORDINATION CHEMISTRY REVIEWS
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- The increasing dynamic, functional complexity of bio-interface materials
- (2018) Bárbara Santos Gomes et al. Nature Reviews Chemistry
- A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study
- (2018) Bradley J. Monk et al. GYNECOLOGIC ONCOLOGY
- Identification of Casiopeina II-gly secondary targets through a systems pharmacology approach
- (2018) Guillermo de Anda-Jáuregui et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
- (2017) Tatjana Lazarević et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent development of transition metal complexes with in vivo antitumor activity
- (2017) Jia-Xin Liang et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Genotoxic assessment of the copper chelated compounds Casiopeinas: Clues about their mechanisms of action
- (2017) Jorge Serment-Guerrero et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia
- (2017) Antonieta Chavez-Gonzalez et al. LEUKEMIA RESEARCH
- Metal complexes in cancer therapy – an update from drug design perspective
- (2017) Umar Ndagi et al. Drug Design Development and Therapy
- A systematic assessment of chemical, genetic, and epigenetic factors influencing the activity of anticancer drug KP1019 (FFC14A)
- (2017) Upendarrao Golla et al. Oncotarget
- Platinum drugs: from Pt(II) compounds, Pt(IV) prodrugs, to Pt nanocrystals/nanoclusters
- (2017) Xi Hu et al. Science Bulletin
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective
- (2016) Enzo Alessio EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Current and future potential of metallo drugs: Revisiting DNA-binding of metal containing molecules and their diverse mechanism of action
- (2016) Mehvash Zaki et al. INORGANICA CHIMICA ACTA
- Evaluation of the radiosensitizing potency of chemotherapeutic agents in prostate cancer cells
- (2016) Colin Rae et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Molecular mode of action of NKP-1339 – a clinically investigated ruthenium-based drug – involves ER- and ROS-related effects in colon carcinoma cell lines
- (2016) Lea S. Flocke et al. INVESTIGATIONAL NEW DRUGS
- Antineoplastic copper coordinated complexes (Casiopeinas) uncouple oxidative phosphorylation and induce mitochondrial permeability transition in cardiac mitochondria and cardiomyocytes
- (2016) Christian Silva-Platas et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Biodistribution of the novel anticancer drug sodium trans -[tetrachloridobis(1 H -indazole)ruthenate(III)] KP-1339/IT139 in nude BALB/c mice and implications on its mode of action
- (2016) Anna K. Bytzek et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Immunological off-target effects of imatinib
- (2016) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- A Systematic Review of Adherence to Oral Antineoplastic Therapies
- (2016) Joseph A. Greer et al. ONCOLOGIST
- Effect of [Cu(4,7-dimethyl-1,10-phenanthroline)(acetylacetonato)]NO3, Casiopeína III-Ea, on the activity of cytochrome P450
- (2016) Cristina Campero-Peredo et al. TOXICOLOGY IN VITRO
- Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)
- (2015) Brian B. Hasinoff et al. BIOCHEMICAL PHARMACOLOGY
- Crosstalk events in the estrogen signaling pathway may affect tamoxifen efficacy in breast cancer molecular subtypes
- (2015) Guillermo de Anda-Jáuregui et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
- (2015) E. Martinez-Balibrea et al. MOLECULAR CANCER THERAPEUTICS
- Third row transition metals for the treatment of cancer
- (2015) T. C. Johnstone et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- Synthesis, crystal structure, properties, and nuclease activity of a new Cu(II) complex [Cu(L)2(Py)2(H2O)] (HL = N-(5-(4-methylphenyl)-[1,3,4]-thiadiazole-2-yl)toluenesulfonamide)
- (2015) A. C. Hangan et al. RUSSIAN JOURNAL OF COORDINATION CHEMISTRY
- Metallodrugs in Medicinal Inorganic Chemistry
- (2014) Katja Dralle Mjos et al. CHEMICAL REVIEWS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- A phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapy
- (2014) YU PENG et al. Oncology Letters
- Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
- (2013) Francesco Tadini-Buoninsegni et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Platinum Compounds: A Hope for Future Cancer Chemotherapy
- (2013) Imran Ali et al. Anti-Cancer Agents in Medicinal Chemistry
- Final Results of Phase III SYMMETRY Study: Randomized, Double-Blind Trial of Elesclomol Plus Paclitaxel Versus Paclitaxel Alone As Treatment for Chemotherapy-Naive Patients With Advanced Melanoma
- (2013) Steven J. O'Day et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacokinetics and hematotoxicity of a novel copper-based anticancer agent: Casiopeina III-Ea, after a single intravenous dose in rats
- (2012) Guadalupe Vértiz et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
- (2012) Akiko Kuwahara et al. International Journal of Medical Sciences
- Pharmacokinetic study of sodium trans[tetrachlorobis(1H-indazole)-ruthenate (III)]/-indazole hydrochloride (1:1.1) (FFC14A) in patients with solid tumors
- (2011) M.M. Henke et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Approaching tumour therapy beyond platinum drugs
- (2011) A. Bergamo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Comparative Nephrotoxicity of Cisplatin and Nedaplatin:Mechanisms and Histopathological Characteristics
- (2011) Takeki Uehara et al. Journal of Toxicologic Pathology
- Structure of N-(5-ethyl-[1,3,4]-thiadiazole-2-yl)toluenesulfonamide by combined X-ray powder diffraction, 13C solid-state NMR and molecular modelling
- (2010) Adriana Hangan et al. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE
- Ruthenium-based chemotherapeutics: are they ready for prime time?
- (2010) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oxaliplatin in First-line Therapy for Advanced Non–Small-Cell Lung Cancer
- (2010) Luis E. Raez et al. Clinical Lung Cancer
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Intracellular protein binding patterns of the anticancer ruthenium drugs KP1019 and KP1339
- (2010) Petra Heffeter et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- ProLindac™ (AP5346): A review of the development of an HPMA DACH platinum Polymer Therapeutic
- (2009) David P Nowotnik et al. ADVANCED DRUG DELIVERY REVIEWS
- KP1019, A New Redox-Active Anticancer Agent - Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
- (2008) Christian G. Hartinger et al. CHEMISTRY & BIODIVERSITY
- Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
- (2008) H. Choy et al. CLINICAL CANCER RESEARCH
- Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
- (2008) Edward L. Korn et al. JOURNAL OF CLINICAL ONCOLOGY
- Elesclomol induces cancer cell apoptosis through oxidative stress
- (2008) J. R. Kirshner et al. MOLECULAR CANCER THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now